好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Treatment of Recurrent Primary Central Nervous System Lymphoma Patients with anti-PD1 Antibody Nivolumab
Neuro-oncology
(-)
280
Authors/Disclosures
Lakshmi Nayak, MD (Dana Farber Cancer Institute, Center for Neuro-oncology)
PRESENTER
Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceutical. An immediate family member of Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BraveBio. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kite/Gilead. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genmab. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curis. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miltenyi. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Nayak has received publishing royalties from a publication relating to health care.
Fabio M. Iwamoto, MD No disclosure on file